Concepedia

Vasile Musteata

VM

Statistics

Publications

1

Citations

12

H-Index

1

Active since

2022

Affiliations

Levine Cancer Institute(Current)

Vasile Musteata is an author at Levine Cancer Institute specializing in immunotherapy, anti-cd20 therapy, and relapsed diffuse large b-cell lymphoma.

Publications per year

2022–2022

1

Publications

1

Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma

Paul A. Hamlin, Vasile Musteata, Steven I. Park et al. · Cancer Research Communications · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

1–1 of 1